COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant
The evidence regarding thrombotic microangiopathy (TMA) related to Coronavirus Infectious Disease 2019 (COVID-19) in patients with complement gene mutations as a cause of acute kidney injury (AKI) are limited. We presented the case of a 23-year-old male patient admitted with an asymptomatic form of...
Saved in:
Main Authors: | Pinte Larisa (Author), Sorohan Bogdan Marian (Author), Prohászka Zoltán (Author), Gherghiceanu Mihaela (Author), Băicuş Cristian (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New-onset complement-mediated thrombotic microangiopathy during the COVID-19 pandemic
by: Christof Aigner, et al.
Published: (2024) -
Extrarenal manifestations of complement mediated thrombotic microangiopathies
by: Johannes eHofer, et al.
Published: (2014) -
Complement-Mediated Thrombotic Microangiopathy and Spontaneous Splenic Rupture Associated With Cytomegalovirus Infection
by: Sadia Shabir MD, et al.
Published: (2023) -
Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
by: Gianluigi Ardissino, et al.
Published: (2022) -
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022)